tiprankstipranks
Lipocine (DE:2VT)
FRANKFURT:2VT

Lipocine (2VT) Stock Investors

0 Followers
Based on 644,394 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold DE:2VT
On average, investors allocate 3.26% of their portfolios to DE:2VT
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 644,394 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding 2VT

0.8%
Last 7
Days
3.0%
Last 30
Days
Percentages indicate the change in the number of portfolios holding DE:2VT, out of 644,394 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

2VT Investor Activity

No data currently available
Based on the activity of 12,089 investors who made their portfolios public
The table shows changes in 2VT in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

2VT Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Tilray
3.93%
-0.91%
-1.21%
1.49B
Basic Materials
Marathon Digital Holdings
4.49%
-0.61%
-0.19%
1.54B
Technology
Blink Charging Co
3.92%
-0.10%
+4.69%
431.25M
Services
Riot Platforms
4.59%
>-0.01%
+0.72%
1.94B
Financial
Li Auto
5.46%
+0.70%
+4.91%
28.47B
Consumer Goods
Syros Pharmaceuticals
3.89%
-1.22%
-4.64%
82.38M
Healthcare
Nikola
5.38%
-0.70%
-2.43%
526.33M
Consumer Goods
XPeng, Inc. ADR
4.49%
-0.46%
+1.19%
7.80B
Consumer Goods
Moderna
5.63%
-0.47%
-0.38%
48.12B
Healthcare
General Electric
5.90%
+0.67%
+3.47%
113.53B
Industrial Goods
Based on the activity of 644,394 active portfolios
Open your Smart Portfolio

2VT Investor Analysis

DE:2VT investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
15.4%
of DE:2VT holders
are under 35
Average Segment Performance
Average P/E Ratio28.41
Beta4.96
Dividend Yield4.96%
DE:2VT investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
67.0%
of DE:2VT holders
are between 35–55
Average Segment Performance
Average P/E Ratio27.30
Beta4.92
Dividend Yield5.93%
DE:2VT investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
17.6%
of DE:2VT holders
are over 55
Average Segment Performance
Average P/E Ratio31.51
Beta0.41
Dividend Yield5.49%
Overview of age group and performance of DE:2VT stock investors
See who invests in 2VT according to age group and performance.

FAQ

How many retail Investors hold DE:2VT?
<0.1% of TipRanks' retail investors hold DE:2VT in their portfolios.
    What is DE:2VT Investor Sentiment?
    DE:2VT’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of DE:2VT in the last 7 days?
      ▲ 0.8% of TipRanks' retail investors changed their holding of DE:2VT in the last 7 days.
        What percentage of retail investors changed their holding of DE:2VT in the last 30 days?
        ▼ 3.0% of TipRanks' retail investors changed their holding of DE:2VT in the last 30 days.
          What is the average age of retail investors who hold DE:2VT?
          The average age of DE:2VT Holders is between 35–55.
            What other stocks have DE:2VT investors also bought?
            DE:2VT Investors also bought TLRY, MARA, BLNK, RIOT, LI, SYRS, NKLA, XPEV, MRNA, GE.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ACADACADIA Pharmaceuticals
              AGENAgenus
              ABCAmerisourceBergen
              BCRXBioCryst
              BLRXBioline RX Ltd Sponsored ADR
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis